These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38151738)

  • 1. Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population.
    Lundberg M; Maurer R; Tchekmedyian R; Mullur J; Bensko JC; Buchheit KM; Laidlaw TM
    Allergy Asthma Proc; 2024 Jan; 45(1):5-13. PubMed ID: 38151738
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life.
    Tchekmedyian R; Lundberg M; Buchheit KM; Maurer R; Gakpo D; Mullur J; Bensko JC; Laidlaw TM
    Clin Exp Allergy; 2022 Dec; 52(12):1414-1421. PubMed ID: 35506180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Psychometric Validation of the Olfactory Dysfunction Outcomes Rating.
    Lee JJ; Mahadev A; Kallogjeri D; Peterson AM; Gupta S; Khan AM; Jiramongkolchai P; Schneider JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1132-1139. PubMed ID: 36264557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study.
    Gudziol V; Michel M; Sonnefeld C; Koschel D; Hummel T
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1487-1493. PubMed ID: 27830335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and Reliability of the French Short Version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS).
    Leclercq C; Chiesa-Estomba CM; Horoi M; Le Bon SD; Hans S; Distinguin L; Chekkoury-Idrissi Y; Circiu MP; Khalife M; Saussez S; Lechien JR
    Ear Nose Throat J; 2024 Feb; 103(2):NP113-NP117. PubMed ID: 34463149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease.
    Ta V; White AA
    J Allergy Clin Immunol Pract; 2015; 3(5):711-8. PubMed ID: 25858054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfaction-associated quality of life: Polish adaptation and validation of a Questionnaire of Olfactory Disorders (QOD-PL) in patients with chronic rhinosinusitis.
    Resler K; Oleszkiewicz A; Frączek M; Morawska-Kochman M; Resler A; Zatoński T; Hummel T
    Adv Clin Exp Med; 2024 Feb; 33(2):143-150. PubMed ID: 37676099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of a french version of the olfactory disorders questionnaire.
    Lechien JR; Vaira LA; Le Bon SD; Geerts R; Boscolo-Rizzo P; Saussez S
    J Otolaryngol Head Neck Surg; 2022 Oct; 51(1):36. PubMed ID: 36182947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired eating-related quality of life in chronic rhinosinusitis.
    Rowan NR; Soler ZM; Storck KA; Othieno F; Ganjaei KG; Smith TL; Schlosser RJ
    Int Forum Allergy Rhinol; 2019 Mar; 9(3):240-247. PubMed ID: 30485716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease.
    Buchheit KM; Sohail A; Hacker J; Maurer R; Gakpo D; Bensko JC; Taliaferro F; Ordovas-Montanes J; Laidlaw TM
    J Allergy Clin Immunol; 2022 Aug; 150(2):415-424. PubMed ID: 35460728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
    Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
    J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD.
    Tripathi SH; Corr A; Kumar A; Ungerer H; Salmon M; Adappa ND; Bosso JV
    Allergy Asthma Proc; 2023 Jan; 44(1):78-80. PubMed ID: 36719696
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease Based on the 12-Item Short Form Survey.
    Locke TB; Sweis AM; Douglas JE; Ig-Izevbekhai KI; Stevens EM; Civantos AM; McCarty EB; Kumar A; Kohanski MA; Kennedy DW; Palmer JN; Bosso JV; Adappa ND
    Am J Rhinol Allergy; 2021 Nov; 35(6):790-797. PubMed ID: 33691498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in men and women suffering from CRSwNP and AERD in quality of life.
    Bartosik TJ; Liu DT; Campion NJ; Villazala-Merino S; Janik S; Dahm V; Mueller CA; Vyskocil E; Stanek V; Quint T; Bangert C; Eckl-Dorna J; Schneider S
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1419-1427. PubMed ID: 33063145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Rhinosinusitis Outcomes of Patients With Aspirin-Exacerbated Respiratory Disease Treated With Budesonide Irrigations: A Case Series.
    Talat R; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Ann Otol Rhinol Laryngol; 2022 Oct; 131(10):1130-1136. PubMed ID: 34775833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Psychometric Validation of the Taste And Smell Tool for Evaluation (TASTE) Questionnaire.
    Niklassen AS; Christensen KB; Fjaeldstad AW; Ovesen T
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1164-1172. PubMed ID: 36326741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of the Parosmia Olfactory Dysfunction Outcomes Rating (DisODOR).
    Ioerger P; Kallogjeri D; Roland L; Schneider JS; Piccirillo JF; Farrell NF
    Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1654-1661. PubMed ID: 37622602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive significance of the questionnaire of olfactory disorders-negative statements for olfactory loss in patients with chronic rhinosinusitis.
    Yuan F; Wu D; Wei Y
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5253-5262. PubMed ID: 35718822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.